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Abstract
A catalytic enantioselective approach to the eudesmane sesquiterpenoids is reported. The strategic
use of a palladium-catalyzed enantioselective alkylation of vinylogous ester substrates forged the C
(10) all-carbon quaternary center. This key transformation enabled a diastereoselective olefin
hydrogenation to create the syn stereochemistry at C(7). The devised synthetic strategy allowed for
the preparation of the antibacterial agent (+)-carissone and a formal synthesis of the P/Q-type calcium
channel blocker (–)-α-eudesmol.
The flowering plants of the family Asteraceae (Compositae) have many historical uses,
including rubber, medicines, edible oils, vegetables, and pesticides.1 Among these flora are a
large number of species that are abundant in structurally diverse sesquiterpenoids, particularly
ones that contain the eudesmane skeleton (Figure 1). Over 1000 eudesmanes have been
identified from these sources, with their structures diverging based on oxygenation and
oxidation patterns within the carbon framework.
This ever-growing2 class of important secondary metabolites possesses a wide range of
biological properties, including plant growth inhibition, insect antifeedant, antibacterial,
antifungal, and antitumor activities. Representative eudesmanes include antibacterial agents
(+)-carissone (1)3 and (+)-3-oxocostusic acid (2),4 as well as P/Q-type calcium channel blocker
(−)-α-eudesmol (3)5 (Figure 1). These examples typify common structural motifs within this
class of sesquiterpenoids, including the C(10) all-carbon quaternary stereocenter and
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stereogenic C(7) substituent. The structural similarities and interesting biology associated with
this class of molecules has stimulated several synthetic efforts,6,7,8 most of which employ
semi-synthetic or chiral pool strategies. To date, no catalytic asymmetric approaches toward
these eudesmanes have been developed. Herein we report an approach9 that incorporates our
recent method for the catalytic asymmetric formation of enantioenriched all-carbon quaternary
stereocenters into a general synthetic strategy for this class of sesquiterpenoids.
In devising a strategy for the total synthesis of the eudesmanes, we simplified our target to
enone 5, which has been utilized in the preparation of structures such as 4,6d and itself embodies
many features present in various family members (cf. 5 and 1, 2) (Figure 2). We envisioned
that the stereochemistry of the C(7) substituent could arise by means of the diastereoselective
hydrogenation of a substituted cyclohexene (i.e., 6), the stereochemical outcome of which
would be controlled by the C(10) quaternary stereocenter. This cyclohexene could be
obtainable from a ring-closing methathesis of triolefin 7, which would be derived from an
appropriately substituted α-quaternary ketone (i.e., 8). Thus, the key control element in the
design of this synthetic strategy is the C(10) quaternary stereocenter,10 and we therefore sought
to develop an efficient and selective means for the preparation of this moiety.
The enantioselective alkylation of ketone enolates is an area of intense investigation in our
laboratory.11 This method has resulted in the preparation of wide range of carbonyl compounds
with adjacent quaternary stereocenters with high levels of selectivity and excellent yields, some
of which have proved valuable in synthetic endeavors.12 The application of α-quaternary
ketones such as 8 for the devised strategy would require a carbonyl transposition (i.e., 8 →
7), and we therefore chose to exploit the unique properties of vinylogous esters (i.e., 8 where
R2 = OR) pioneered by Stork and Danheiser13 for this purpose.
Our initial studies for the asymmetric generation of quaternary stereocenters utilitzing
vinylgous ester derivatives focused on enol carbonates due to preliminary investigations12c,
14 that have demonstrated successes for similar substrates. Exposure of allyl enol carbonate
9 to typical reaction conditions consisting of a palladium(0) catalyst and ligand (S)-1215 in
toluene generated vinylogous ester (+)-13, albeit in variable yield and selectivity (Table 1,
entry 1). Unfortunately, the instability of 9 impeded further studies as these results were highly
dependent on the composition of this enol carbonate.16 Given the range of substrate
possibilities for this transformation,11d we next focused on racemic β-ketoester (±)-10.
Surprisingly, this substrate proved only modestly reactive at 50 °C, producing ketone (+)-13
in 19% yield and 79% ee (entry 2).17 Increasing the reaction temperature to 80 °C enabled
complete conversion to ketone (+)-13, although with slightly reduced selectivity (entry 3). As
the lack of reactivity seemed to be a major complication with this substrate, we considered
vinylogous thioesters (i.e., (±)-11) for their reported activation properties.14 Indeed, racemic
β-ketoester (±)-11 did prove more reactive and produced ketone (+)-14 at 50 °C in good yield
and 92% ee (entry 4). A screen of solvents revealed that benzene (entry 5) and ethereal solvents
(entries 6 and 7) provided similar selectivities to toluene.
With optimal conditions for the preparation of 14, we sought to demonstrate the feasibility of
using this ketone for the total synthesis of (+)-carissone (1). Accordingly, racemic β-ketoester
(±)-11 was converted to (−)-14 in 85% yield18 and 92% ee using ligand (R)-12, to correlate
with the natural antipode of 1 (Scheme 2). Subsequent conversion of vinylogous thioester
(−)-14 into vinylogous ester (−)-15 was achieved with sodium methoxide in refluxing
methanol. Exposure of the resulting vinylogous ester to the substituted allylmagnesium
bromide generated from 1619 and magnesium provided enone (−)-17 in 94% yield. The success
of allylmagnesium bromide additions to vinylogous ester (−)-15 encouraged us to investigate
similar reactions of various organometallic reagents with vinylogous thioester (−)-14, however,
several conditions provided intractable mixtures with no desired products.20 Nonetheless, ring-
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closing metathesis of enone (−)-17 using Grubbs’ catalyst 1821 efficiently prepared the desired
substrate (i.e., (−)-19) for the diastereoselective hydrogenation. Gratifyingly, heterogeneous
hydrogenation utilizing Rh/Al2O3 catalyst22 in methanol, followed by TBS cleavage, provided
alcohol (+)-20 in good overall yield with excellent diastereoselectivity.23 This notable
transformation generates alcohol (+)-20 with the C(10) and C(7) stereocenters in the desired
syn configuration required for 1. Conversion of alcohol (+)-20 to ester (+)-21 was achieved by
a two-step process involving Dess–Martin oxidation,24 followed by chlorite oxidation25 with
diazomethane workup.
The availability of ester (+)-21 in the desired configuration enabled preparation of (+)-carissone
(1) in short order. Diastereoselective reduction of the enone carbonyl under Luche conditions,
26 followed by treatment of the resulting alcohol with methylmagnesium bromide6m provided
diol (+)-2227 in 71% yield (Scheme 3). The preparation of this diol intersects Aoyama’s
synthesis (−)-α-eudesmol (3)6e and represents a formal total synthesis. Furthermore, facile
allylic oxidation with manganese dioxide6a gave (+)-carissone (1), having spectroscopic data
(1H NMR, 13C NMR, IR, HRMS, optical rotation) identical to that reported for natural 1.
In summary, we have described the palladium-catalyzed asymmetric alkylation of vinylogous
ester substrates and demonstrated the utility of such products in a general synthetic approach
for the total synthesis of the eudesmane sesquiterpenoids. Fundamental to this strategy is the
use of the resulting C(10) quaternary stereocenter to control the C(7) stereochemistry via a
diastereoselective hydrogenation, providing a highly selective and efficient route to the
antibacterial agent (+)-carissone (1). Studies to understand the interplay between substrate
reactivity and selectivity for the asymmetric alkylation of vinylogous ester derivatives, as well
as the use of the resulting enantioenriched products in the synthesis of other bioactive natural
substances28 is currently underway.
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Figure 1.
Representative Eudesmane Sesquiterpenoids
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Scheme 1.
Retrosynthetic Analysis of the Eudesmanes
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Scheme 2.
Enantioselective Synthesis of the Eudesmane Core
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Scheme 3.
End Game for (+)-Carissone (1)
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